CEL-SCI Corp.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About CEL-SCI Corp.
CEL-SCI Corp is a player in the biotechnology sector. It is engaged in the research and development of the treatment of cancer and other diseases using the immune system. The Company's core capabilities include drug discovery, research, development, and manufacturing of complex biological substances. It is focused on the development of Multikine (Leukocyte Interleukin, Injection), investigational immunotherapy under development for the treatment of certain head and neck cancers, and anal warts or cervical dysplasia.
/ 
Frequently asked questions
To buy CEL-SCI Corp. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for CEL-SCI Corp. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for CEL-SCI Corp. is CVM:xase. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
CEL-SCI Corp. has its primary listing on NYSE American. You can trade CEL-SCI Corp. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, CEL-SCI Corp. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include CEL-SCI Corp. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like CEL-SCI Corp..